TRANSFUSION CLINIQUE ET BIOLOGIQUE

Scope & Guideline

Connecting biochemistry and hematology for transformative care.

Introduction

Immerse yourself in the scholarly insights of TRANSFUSION CLINIQUE ET BIOLOGIQUE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageMulti-Language
ISSN1246-7820
PublisherELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 1994 to 2024
AbbreviationTRANSFUS CLIN BIOL / Transfu. Clin. Biol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE

Aims and Scopes

The journal 'Transfusion Clinique et Biologique' focuses on advancing the field of transfusion medicine through research, clinical practice, and education. It encompasses a wide range of topics related to blood transfusion, including safety, efficacy, and ethical considerations, while promoting the integration of new technologies and methodologies.
  1. Transfusion Safety and Efficacy:
    Research dedicated to ensuring the safety of blood products through rigorous screening, testing, and transfusion protocols to minimize risks associated with transfusions.
  2. Clinical Applications and Management:
    Exploration of various clinical practices in transfusion medicine, including patient blood management, the management of specific conditions, and evaluation of transfusion outcomes.
  3. Emerging Technologies and Innovations:
    Focus on the application of new technologies in transfusion practices, including molecular techniques, artificial intelligence, and forecasting models for blood component needs.
  4. Ethical and Social Considerations:
    Discussion of ethical issues related to blood donation and transfusion practices, including donor deferral policies and the implications of emerging infectious diseases.
  5. Public Health and Epidemiology in Transfusion:
    Study of the epidemiological aspects of blood transfusion, including the prevalence of transfusion-transmissible infections and the impact of public health policies on blood safety.
Recent publications in 'Transfusion Clinique et Biologique' indicate several emerging themes that reflect the evolving landscape of transfusion medicine. These trends highlight the journal's responsiveness to contemporary challenges and advancements in the field.
  1. Patient Blood Management (PBM):
    There is a growing emphasis on PBM practices that optimize the use of blood products and improve patient outcomes, reflecting a shift towards more patient-centered approaches in transfusion medicine.
  2. Impact of COVID-19 on Blood Donation and Transfusion Practices:
    Research exploring the effects of the COVID-19 pandemic on blood supply, donor behavior, and transfusion practices has surged, indicating an urgent need to adapt to public health challenges.
  3. Molecular and Genetic Testing in Transfusion Medicine:
    An increase in studies focusing on molecular testing, including genetic screening for transfusion compatibility and infectious disease detection, showcases the integration of advanced technologies into routine practice.
  4. Ethical Considerations in Transfusion Practices:
    There is a notable rise in discussions surrounding the ethical implications of transfusion medicine, particularly regarding donor deferral policies and the management of high-risk populations.
  5. Forecasting and Predictive Modeling for Blood Supply:
    The application of predictive models and algorithms to forecast blood component needs and donor behavior is becoming more prevalent, reflecting the journal's commitment to innovative practices in transfusion management.

Declining or Waning

As the field of transfusion medicine evolves, certain themes appear to be losing prominence. This decline may reflect shifts in research priorities or advancements in technology that render previous approaches less relevant.
  1. Traditional Blood Collection Methods:
    Research on conventional blood collection techniques and practices is diminishing as newer, more efficient methods are developed, and there is a growing emphasis on automation and technology in blood collection.
  2. Generalized Blood Donation Campaigns:
    Public health campaigns that do not target specific donor demographics or motivations are becoming less common as more tailored approaches are adopted to improve donor recruitment and retention.
  3. Focus on Alloimmunization without Contextual Factors:
    While alloimmunization remains a concern, the exploration of this issue without considering genetic, environmental, or patient-specific factors is appearing less frequently in recent publications.
  4. In-depth Historical Reviews of Transfusion Practices:
    The trend of publishing extensive historical reviews on transfusion practices has decreased, likely due to the focus shifting towards contemporary challenges and innovations in the field.
  5. Single-Disease Focus in Transfusion Research:
    Research centered exclusively on single diseases without considering broader implications or interdisciplinary approaches is becoming less prevalent, as there is a push for more holistic studies.

Similar Journals

Asian Journal of Transfusion Science

Advancing transfusion science for a healthier tomorrow.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0973-6247Frequency: 2 issues/year

Asian Journal of Transfusion Science, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, is a prominent open-access journal dedicated to the interdisciplinary fields of hematology and immunology. With an ISSN of 0973-6247 and E-ISSN 1998-3565, it serves as a crucial platform for researchers, clinicians, and students from around the globe, facilitating the dissemination of high-quality, peer-reviewed research. Established in 2007, the journal has consistently aimed to advance scientific knowledge in transfusion practices, enhancing patient care and safety in transfusion medicine. Despite its recent categorization in the Q4 quartile within both Hematology and Immunology, the journal is making strides toward greater visibility in the academic community, with plans for expanded reach and increased citation impact. With its commitment to open-access publishing, the Asian Journal of Transfusion Science ensures that invaluable research findings are readily accessible to all stakeholders, thereby bolstering collaborative efforts in transfusion science and related disciplines.

INTERNATIONAL JOURNAL OF HEMATOLOGY

Delivering Cutting-Edge Findings in Hematology
Publisher: SPRINGER JAPAN KKISSN: 0925-5710Frequency: 12 issues/year

The INTERNATIONAL JOURNAL OF HEMATOLOGY, published by SPRINGER JAPAN KK, serves as a critical platform for advancing research in the field of hematology. With a prestigious history spanning over three decades from 1991 to 2024, this journal is recognized for its impactful contributions, evidenced by its Q2 category ranking in Hematology for 2023, and its notable position at rank #71 out of 137 in the Scopus Medicine Hematology category. Researchers and professionals within the hematology community benefit from the journal's rigorous peer-reviewed articles that cover a wide range of topics, including clinical studies, basic research, and novel therapeutic strategies. Though currently non-open access, it provides essential insights and findings to an audience passionate about the latest advancements in blood disorders and treatments. Situated in Japan, the journal not only showcases high-quality research but also fosters a global exchange of knowledge in hematology, making it a significant resource for scholars, practitioners, and students alike.

Hematology

Advancing Hematology: Where Innovation Meets Insight
Publisher: TAYLOR & FRANCIS LTDISSN: 1024-5332Frequency: 1 issue/year

Hematology is a distinguished open-access journal published by Taylor & Francis Ltd, dedicated to advancing research and knowledge in the field of hematology. Established in 1996, the journal has continually evolved to meet the needs of a growing community of researchers and practitioners, providing a vital platform for disseminating innovative findings and clinical insights. With its impact factor reflecting a robust commitment to quality scholarship, Hematology has achieved a respectable position in its category as evidenced by its Q3 ranking in the Hematology category and ranks #85 out of 137 in the Scopus index, which positions it in the 38th percentile among its peers. The journal’s open-access policy, initiated in 2019, further enhances its reach and accessibility, allowing a broad audience of professionals, researchers, and students to engage with high-quality research without barriers. By covering a wide range of topics related to blood disorders, treatment methodologies, and emerging therapies, Hematology stands as an essential resource for those dedicated to innovation in this critical area of healthcare.

Clinical Laboratory

Advancing the Frontiers of Clinical Science
Publisher: CLIN LAB PUBLISSN: 1433-6510Frequency: 12 issues/year

Clinical Laboratory is a reputable journal dedicated to the interdisciplinary field of clinical biochemistry, genetics, and molecular biology. Published by CLIN LAB PUBL in Germany, this journal provides a platform for the dissemination of original research, reviews, and key insights into laboratory practices and innovations that play a crucial role in modern medicine and diagnostics. With an ISSN of 1433-6510 and a consistent publication history since its inception in 1964 and converging through 2024, it is indexed within the Scopus database, ranking in the 30th percentile among its peers. Although classified in the third quartile for 2023 in the field, Clinical Laboratory continues to contribute valuable knowledge and fosters collaboration among researchers, professionals, and students. Notably, it does not currently operate as an Open Access journal, which emphasizes its commitment to maintaining high-quality peer-reviewed content accessible through institutional and library subscriptions. For those in the domain, Clinical Laboratory serves as a vital resource for the latest advancements and trends shaping the future of clinical laboratory science.

Transfusionsmedizin

Advancing transfusion science for safer patient care.
Publisher: GEORG THIEME VERLAG KGISSN: 2191-8805Frequency: 4 issues/year

Transfusionsmedizin is a premier journal dedicated to the field of transfusion medicine, published by the renowned GEORG THIEME VERLAG KG. With an ISSN of 2191-8805 and an E-ISSN of 2191-8813, this journal serves as a vital platform for disseminating cutting-edge research and clinical advancements in blood transfusion practices. Although it operates under a subscription model, the journal is committed to high-quality peer-reviewed content that addresses contemporary challenges and innovations in transfusion therapy. By fostering dialogue among researchers, clinicians, and students, Transfusionsmedizin aims to advance patient care and enhance the safety and efficacy of transfusion practices globally. Its contributions are essential for professionals engaged in transfusion science, hematology, and related medical fields, solidifying its reputation as a critical resource for staying abreast of the latest developments in transfusion research.

GEMATOLOGIYA I TRANSFUZIOLOGIYA

Bridging Research and Practice in Hematology
Publisher: MINISTERSTVO ZDRAVOOKHRANENIYAISSN: 0234-5730Frequency: 4 issues/year

GEMATOLOGIYA I TRANSFUZIOLOGIYA is an esteemed journal published by the MINISTERSTVO ZDRAVOOKHRANENIYA in the Russian Federation, focusing on the vital fields of hematology and transfusion medicine. With a rich history dating back to its inception in 1983, the journal plays a significant role in disseminating critical research and advancements in these areas, particularly relevant given the evolving landscape of medical science. As a recognized publication, it is indexed in Scopus and holds a Q4 category ranking in Hematology for 2023, reflecting its niche but important contributions to the field. Researchers, healthcare professionals, and students can look forward to a variety of peer-reviewed articles that not only address contemporary issues but also pave the way for innovative practices in hematology. Although it does not currently offer open access, the journal remains a valuable resource for those seeking to stay informed about the latest findings and developments.

Egyptian Journal of Haematology

Fostering Collaboration for a Healthier Tomorrow in Hematology
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1110-1067Frequency: 4 issues/year

The Egyptian Journal of Haematology, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of hematology, particularly within the context of Egypt and the broader Middle Eastern region. This journal is dedicated to disseminating high-quality research that explores the latest advancements in blood disorders, hematologic malignancies, and transfusion medicine. With a focus on original research, case studies, and reviews, it aims to provide a comprehensive platform for hematologists, researchers, and healthcare professionals to enhance their understanding and management of hematological conditions. Although it is not an open-access journal, the rigorous peer-review process ensures that only the most impactful studies are published, contributing to the journal's reputation in the academic community. The Egyptian Journal of Haematology serves as an essential tool for advancing knowledge, improving clinical outcomes, and fostering collaboration among experts in the field.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Unveiling Cutting-Edge Research in Clinical Pathology
Publisher: OXFORD UNIV PRESS INCISSN: 0002-9173Frequency: 12 issues/year

The American Journal of Clinical Pathology, published by Oxford University Press Inc, stands as a vital resource in the fields of pathology and clinical medicine. With a rich history dating back to 1945 and an impressive impact factor reflected in its Q1 ranking in Pathology and Forensic Medicine, this journal serves as a cornerstone for researchers and professionals seeking to advance their knowledge and practice. Covering a breadth of topics within the discipline, it is recognized in 2023 as ranked #24 out of 208 in its category, highlighting its esteemed reputation within the scientific community. Although the journal does not currently offer open access, its rigorous peer-reviewed articles and cutting-edge research make it an essential addition to any academic or clinical library. The ISSN for print version is 0002-9173, with an E-ISSN of 1943-7722 available for digital access. Researchers, students, and practitioners alike will benefit from its comprehensive scope and commitment to disseminating high-quality scientific inquiry.

Anemia

Fostering collaboration in the fight against blood disorders.
Publisher: HINDAWI LTDISSN: 2090-1267Frequency: 1 issue/year

Anemia is a distinguished open-access journal published by HINDAWI LTD, focusing on the intricate and vital field of hematology and related disciplines. Since its inception in 2010, this journal has been dedicated to advancing our understanding of blood disorders, with a particular emphasis on anemia, through the dissemination of high-quality research that is freely accessible to a global audience. The journal's evolving scope from its founding through 2024 embodies its commitment to include the latest breakthroughs and methodologies in cell biology and hematological research. With its presence in prestigious databases and a tiered ranking that places it in the Q3 category in Hematology and Q4 in Cell Biology as of 2023, Anemia serves as an invaluable resource for researchers, clinicians, and students alike. The journal is indexed with a respectable position in Scopus, ranking 52 out of 137 in Hematology, highlighting its growing influence in the medical and scientific communities. With continued emphasis on open access, Anemia not only fosters collaborative research but also ensures that crucial findings reach those who need them most, enhancing educational outcomes and clinical practices worldwide.

TRANSFUSION MEDICINE REVIEWS

Unlocking insights in transfusion science.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0887-7963Frequency: 4 issues/year

TRANSFUSION MEDICINE REVIEWS is a prestigious journal dedicated to the advanced study of transfusion medicine and its related fields, published by W B SAUNDERS CO-ELSEVIER INC. With an outstanding reputation, it boasts an impressive impact factor and consistently ranks in the top quartile (Q1) across multiple categories, including Biochemistry (Medical), Clinical Biochemistry, and Hematology. Researchers will find valuable insights through its extensive coverage of pertinent topics, with a focus on the integration of clinical practices and laboratory science. While the journal does not currently offer open access, its content remains accessible through various institutional subscriptions, ensuring that vital information is available to the global scientific community. With a continuous publication history from 1987 to 2024, TRANSFUSION MEDICINE REVIEWS serves as a vital resource for academics, healthcare professionals, and students who seek to stay abreast of the latest research findings and clinical practices in transfusion medicine.